TelePeptide review

This is the arrangement we have been looking for. A named microdose product, sold as its own thing, priced below the full-dose version of the same molecule from the same seller — so taking less genuinely costs less, by about a fifth. Almost every other provider either has no low-dose product at all, or has one and charges the same or more for it. The naming deserves credit too: calling the product sub-therapeutic is a plain admission that a smaller dose is a smaller dose, where the convention in this category is to imply the opposite. Then the structure takes most of it back. Every figure on the page, the microdose included, is quoted with annual prepay attached, so each one is a year bought in advance and divided by twelve, and no monthly rung is published for anything at all. If your plan is to start low and adjust as you go, you are being asked to buy a year before finding out how you respond — which is the same trap as everywhere else, wearing better clothes. No milligram appears against any product, including the one named for its dose.

Vs median

Not comparable — no per-month rate is published — the verified string carries no monthly figure

Market

$59–$1300/mo is the full published spread in our ranking

Structure

Charges less for less

Consult

Included in the price

Dietitian

Not included

Labs

Not required

Pricing

Varies by dose, plan or tier

Price last updated

August 2026

TelePeptide does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.

This is the arrangement the whole page has been looking for. A named microdose product, sold as its own thing, priced below the full-dose version of the same molecule from the same seller — taking less costs less, by about a fifth. Almost every other seller either has no low-dose product at all or charges the same or more for it. The naming deserves credit too: calling the product sub-therapeutic is a plain admission that a smaller dose is a smaller dose, where the marketing convention is to imply the opposite. Then the structure takes most of it back. Every figure on the page, the microdose included, is quoted with annual prepay attached, so each one is a year bought in advance and divided by twelve, and no monthly rung is published for anything. A reader whose plan is to start low and adjust is being asked to buy a year before finding out how they respond, which is the same trap as everywhere else wearing better clothes. No milligram appears against any of the products, including the one named for its dose.

Every figure requires an annual prepay — no monthly rung is published for anything.

• The advertised prices are a year's payment divided by twelve.
• No milligram appears, including on the product named for its dose.

TelePeptide is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What microdosing GLP-1 costs
• Low dose vs full dose
• The true annual cost of a plan
• What a flat price costs at a low dose